Global and United States DNA Repair Drugs Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 DNA Repair Drugs Product Introduction
1.2 Market Segments
1.3 Key DNA Repair Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global DNA Repair Drugs Market Size Growth Rate by Type
1.4.2 PARP Inhibitors
1.4.3 Other
1.5 Market by Application
1.5.1 Global DNA Repair Drugs Market Size Growth Rate by Application
1.5.2 Oncological
1.5.3 Stroke
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global DNA Repair Drugs Market Size, Estimates and Forecasts
2.1.1 Global DNA Repair Drugs Revenue 2015-2026
2.1.2 Global DNA Repair Drugs Sales 2015-2026
2.2 Global DNA Repair Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 DNA Repair Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global DNA Repair Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global DNA Repair Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 DNA Repair Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global DNA Repair Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global DNA Repair Drugs Revenue Forecast by Region (2021-2026)
3 Global DNA Repair Drugs Competitor Landscape by Players
3.1 Global Top DNA Repair Drugs Sales by Manufacturers
3.1.1 Global DNA Repair Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global DNA Repair Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global DNA Repair Drugs Manufacturers by Revenue
3.2.1 Global DNA Repair Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global DNA Repair Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global DNA Repair Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by DNA Repair Drugs Revenue in 2019
3.2.5 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global DNA Repair Drugs Price by Manufacturers
3.4 Global DNA Repair Drugs Manufacturing Base Distribution, Product Types
3.4.1 DNA Repair Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers DNA Repair Drugs Product Type
3.4.3 Date of International Manufacturers Enter into DNA Repair Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global DNA Repair Drugs Market Size by Type (2015-2020)
4.1.1 Global DNA Repair Drugs Sales by Type (2015-2020)
4.1.2 Global DNA Repair Drugs Revenue by Type (2015-2020)
4.1.3 DNA Repair Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global DNA Repair Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global DNA Repair Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global DNA Repair Drugs Revenue Forecast by Type (2021-2026)
4.2.3 DNA Repair Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global DNA Repair Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global DNA Repair Drugs Market Size by Application (2015-2020)
5.1.1 Global DNA Repair Drugs Sales by Application (2015-2020)
5.1.2 Global DNA Repair Drugs Revenue by Application (2015-2020)
5.1.3 DNA Repair Drugs Price by Application (2015-2020)
5.2 DNA Repair Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global DNA Repair Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global DNA Repair Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global DNA Repair Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States DNA Repair Drugs Market Size YoY Growth 2015-2026
6.1.1 United States DNA Repair Drugs Sales YoY Growth 2015-2026
6.1.2 United States DNA Repair Drugs Revenue YoY Growth 2015-2026
6.1.3 United States DNA Repair Drugs Market Share in Global Market 2015-2026
6.2 United States DNA Repair Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top DNA Repair Drugs Players by Sales (2015-2020)
6.2.2 United States Top DNA Repair Drugs Players by Revenue (2015-2020)
6.3 United States DNA Repair Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States DNA Repair Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States DNA Repair Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States DNA Repair Drugs Price by Type (2015-2020)
6.4 United States DNA Repair Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States DNA Repair Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States DNA Repair Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States DNA Repair Drugs Price Forecast by Type (2021-2026)
6.5 United States DNA Repair Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States DNA Repair Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States DNA Repair Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States DNA Repair Drugs Price by Application (2015-2020)
6.6 United States DNA Repair Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States DNA Repair Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States DNA Repair Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States DNA Repair Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America DNA Repair Drugs Market Size YoY Growth 2015-2026
7.2 North America DNA Repair Drugs Market Facts & Figures by Country
7.2.1 North America DNA Repair Drugs Sales by Country (2015-2020)
7.2.2 North America DNA Repair Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe DNA Repair Drugs Market Size YoY Growth 2015-2026
8.2 Europe DNA Repair Drugs Market Facts & Figures by Country
8.2.1 Europe DNA Repair Drugs Sales by Country
8.2.2 Europe DNA Repair Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific DNA Repair Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific DNA Repair Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific DNA Repair Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific DNA Repair Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America DNA Repair Drugs Market Size YoY Growth 2015-2026
10.2 Latin America DNA Repair Drugs Market Facts & Figures by Country
10.2.1 Latin America DNA Repair Drugs Sales by Country
10.2.2 Latin America DNA Repair Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa DNA Repair Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa DNA Repair Drugs Sales by Country
11.2.2 Middle East and Africa DNA Repair Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 4SC AG
12.1.1 4SC AG Corporation Information
12.1.2 4SC AG Description and Business Overview
12.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
12.1.4 4SC AG DNA Repair Drugs Products Offered
12.1.5 4SC AG Recent Development
12.2 ARCAGY/ GINECO GROUP
12.2.1 ARCAGY/ GINECO GROUP Corporation Information
12.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
12.2.3 ARCAGY/ GINECO GROUP Sales, Revenue and Gross Margin (2015-2020)
12.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
12.2.5 ARCAGY/ GINECO GROUP Recent Development
12.3 Bristol Myers Squibb
12.3.1 Bristol Myers Squibb Corporation Information
12.3.2 Bristol Myers Squibb Description and Business Overview
12.3.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
12.3.5 Bristol Myers Squibb Recent Development
12.4 British Columbia Cancer Agency
12.4.1 British Columbia Cancer Agency Corporation Information
12.4.2 British Columbia Cancer Agency Description and Business Overview
12.4.3 British Columbia Cancer Agency Sales, Revenue and Gross Margin (2015-2020)
12.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
12.4.5 British Columbia Cancer Agency Recent Development
12.5 Cambridge University Hospitals NHS Foundation Trust
12.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
12.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
12.5.3 Cambridge University Hospitals NHS Foundation Trust Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
12.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
12.6 Genentech
12.6.1 Genentech Corporation Information
12.6.2 Genentech Description and Business Overview
12.6.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Genentech DNA Repair Drugs Products Offered
12.6.5 Genentech Recent Development
12.7 Georgetown University
12.7.1 Georgetown University Corporation Information
12.7.2 Georgetown University Description and Business Overview
12.7.3 Georgetown University Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Georgetown University DNA Repair Drugs Products Offered
12.7.5 Georgetown University Recent Development
12.8 German Breast Group
12.8.1 German Breast Group Corporation Information
12.8.2 German Breast Group Description and Business Overview
12.8.3 German Breast Group Sales, Revenue and Gross Margin (2015-2020)
12.8.4 German Breast Group DNA Repair Drugs Products Offered
12.8.5 German Breast Group Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Corporation Information
12.9.2 GlaxoSmithKline Description and Business Overview
12.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
12.9.5 GlaxoSmithKline Recent Development
12.10 Jiangsu Hengrui Medicine
12.10.1 Jiangsu Hengrui Medicine Corporation Information
12.10.2 Jiangsu Hengrui Medicine Description and Business Overview
12.10.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
12.10.5 Jiangsu Hengrui Medicine Recent Development
12.11 4SC AG
12.11.1 4SC AG Corporation Information
12.11.2 4SC AG Description and Business Overview
12.11.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
12.11.4 4SC AG DNA Repair Drugs Products Offered
12.11.5 4SC AG Recent Development
12.12 Jonsson Comprehensive Cancer Center
12.12.1 Jonsson Comprehensive Cancer Center Corporation Information
12.12.2 Jonsson Comprehensive Cancer Center Description and Business Overview
12.12.3 Jonsson Comprehensive Cancer Center Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Jonsson Comprehensive Cancer Center Products Offered
12.12.5 Jonsson Comprehensive Cancer Center Recent Development
12.13 Karyopharm Therapeutics
12.13.1 Karyopharm Therapeutics Corporation Information
12.13.2 Karyopharm Therapeutics Description and Business Overview
12.13.3 Karyopharm Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Karyopharm Therapeutics Products Offered
12.13.5 Karyopharm Therapeutics Recent Development
12.14 KuDOS Pharmaceuticals
12.14.1 KuDOS Pharmaceuticals Corporation Information
12.14.2 KuDOS Pharmaceuticals Description and Business Overview
12.14.3 KuDOS Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.14.4 KuDOS Pharmaceuticals Products Offered
12.14.5 KuDOS Pharmaceuticals Recent Development
12.15 National Health Service
12.15.1 National Health Service Corporation Information
12.15.2 National Health Service Description and Business Overview
12.15.3 National Health Service Sales, Revenue and Gross Margin (2015-2020)
12.15.4 National Health Service Products Offered
12.15.5 National Health Service Recent Development
12.16 National Institutes of Health
12.16.1 National Institutes of Health Corporation Information
12.16.2 National Institutes of Health Description and Business Overview
12.16.3 National Institutes of Health Sales, Revenue and Gross Margin (2015-2020)
12.16.4 National Institutes of Health Products Offered
12.16.5 National Institutes of Health Recent Development
12.17 Tesaro
12.17.1 Tesaro Corporation Information
12.17.2 Tesaro Description and Business Overview
12.17.3 Tesaro Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Tesaro Products Offered
12.17.5 Tesaro Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key DNA Repair Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 DNA Repair Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. DNA Repair Drugs Market Segments
Table 2. Ranking of Global Top DNA Repair Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global DNA Repair Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of PARP Inhibitors
Table 5. Major Manufacturers of Other
Table 6. Global DNA Repair Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global DNA Repair Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global DNA Repair Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global DNA Repair Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global DNA Repair Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global DNA Repair Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global DNA Repair Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global DNA Repair Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Repair Drugs as of 2019)
Table 16. DNA Repair Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. DNA Repair Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers DNA Repair Drugs Price (2015-2020) (USD/Unit)
Table 19. DNA Repair Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers DNA Repair Drugs Product Type
Table 21. Date of International Manufacturers Enter into DNA Repair Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global DNA Repair Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global DNA Repair Drugs Sales Share by Type (2015-2020)
Table 25. Global DNA Repair Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global DNA Repair Drugs Revenue Share by Type (2015-2020)
Table 27. DNA Repair Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global DNA Repair Drugs Sales Share by Type (2021-2026)
Table 29. Global DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global DNA Repair Drugs Sales Share by Application (2015-2020)
Table 31. Global DNA Repair Drugs Sales Share by Application (2021-2026)
Table 32. Global DNA Repair Drugs Sales Market Share Forecast by Application (2021-2026)
Table 33. Global DNA Repair Drugs Revenue by Application (2015-2020) (US$ Million)
Table 34. Global DNA Repair Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States DNA Repair Drugs Sales (K Units) of Key Companies (2015-2020)
Table 36. United States DNA Repair Drugs Sales Share by Company (2015-2020)
Table 37. United States DNA Repair Drugs Revenue (US$ Million) by Company (2015-2020)
Table 38. United States DNA Repair Drugs Sales (K Units) by Type (2015-2020)
Table 39. United States DNA Repair Drugs Sales Share by Type (2015-2020)
Table 40. United States DNA Repair Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States DNA Repair Drugs Price (K Units) by Type (2015-2020)
Table 42. United States DNA Repair Drugs Sales (K Units) by Type (2021-2026)
Table 43. United States DNA Repair Drugs Sales Share by Type (2021-2026)
Table 44. United States DNA Repair Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States DNA Repair Drugs Revenue Share by Type (2021-2026)
Table 46. United States DNA Repair Drugs Price (K Units) by Type (2021-2026)
Table 47. United States DNA Repair Drugs Sales (K Units) by Application (2015-2020)
Table 48. United States DNA Repair Drugs Sales Share by Application (2015-2020)
Table 49. United States DNA Repair Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States DNA Repair Drugs Sales (K Units) by Application (2021-2026)
Table 51. United States DNA Repair Drugs Sales Share by Application (2021-2026)
Table 52. United States DNA Repair Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States DNA Repair Drugs Revenue Share by Application (2021-2026)
Table 54. North America DNA Repair Drugs Sales by Country (2015-2020) (K Units)
Table 55. North America DNA Repair Drugs Sales Market Share by Country (2015-2020)
Table 56. North America DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. North America DNA Repair Drugs Revenue Market Share by Country (2015-2020)
Table 58. Europe DNA Repair Drugs Sales by Country (2015-2020) (K Units)
Table 59. Europe DNA Repair Drugs Sales Market Share by Country (2015-2020)
Table 60. Europe DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe DNA Repair Drugs Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific DNA Repair Drugs Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific DNA Repair Drugs Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific DNA Repair Drugs Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific DNA Repair Drugs Revenue Market Share by Region (2015-2020)
Table 66. Latin America DNA Repair Drugs Sales by Country (2015-2020) (K Units)
Table 67. Latin America DNA Repair Drugs Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America DNA Repair Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa DNA Repair Drugs Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa DNA Repair Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa DNA Repair Drugs Revenue Market Share by Country (2015-2020)
Table 74. 4SC AG Corporation Information
Table 75. 4SC AG Description and Business Overview
Table 76. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. 4SC AG DNA Repair Drugs Product
Table 78. 4SC AG Recent Development
Table 79. ARCAGY/ GINECO GROUP Corporation Information
Table 80. ARCAGY/ GINECO GROUP Description and Business Overview
Table 81. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. ARCAGY/ GINECO GROUP Product
Table 83. ARCAGY/ GINECO GROUP Recent Development
Table 84. Bristol Myers Squibb Corporation Information
Table 85. Bristol Myers Squibb Description and Business Overview
Table 86. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Bristol Myers Squibb Product
Table 88. Bristol Myers Squibb Recent Development
Table 89. British Columbia Cancer Agency Corporation Information
Table 90. British Columbia Cancer Agency Description and Business Overview
Table 91. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. British Columbia Cancer Agency Product
Table 93. British Columbia Cancer Agency Recent Development
Table 94. Cambridge University Hospitals NHS Foundation Trust Corporation Information
Table 95. Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
Table 96. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Cambridge University Hospitals NHS Foundation Trust Product
Table 98. Cambridge University Hospitals NHS Foundation Trust Recent Development
Table 99. Genentech Corporation Information
Table 100. Genentech Description and Business Overview
Table 101. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Genentech Product
Table 103. Genentech Recent Development
Table 104. Georgetown University Corporation Information
Table 105. Georgetown University Description and Business Overview
Table 106. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Georgetown University Product
Table 108. Georgetown University Recent Development
Table 109. German Breast Group Corporation Information
Table 110. German Breast Group Description and Business Overview
Table 111. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. German Breast Group Product
Table 113. German Breast Group Recent Development
Table 114. GlaxoSmithKline Corporation Information
Table 115. GlaxoSmithKline Description and Business Overview
Table 116. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. GlaxoSmithKline Product
Table 118. GlaxoSmithKline Recent Development
Table 119. Jiangsu Hengrui Medicine Corporation Information
Table 120. Jiangsu Hengrui Medicine Description and Business Overview
Table 121. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Jiangsu Hengrui Medicine Product
Table 123. Jiangsu Hengrui Medicine Recent Development
Table 124. Johnson & Johnson Corporation Information
Table 125. Johnson & Johnson Description and Business Overview
Table 126. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Johnson & Johnson Product
Table 128. Johnson & Johnson Recent Development
Table 129. Jonsson Comprehensive Cancer Center Corporation Information
Table 130. Jonsson Comprehensive Cancer Center Description and Business Overview
Table 131. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Jonsson Comprehensive Cancer Center Product
Table 133. Jonsson Comprehensive Cancer Center Recent Development
Table 134. Karyopharm Therapeutics Corporation Information
Table 135. Karyopharm Therapeutics Description and Business Overview
Table 136. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Karyopharm Therapeutics Product
Table 138. Karyopharm Therapeutics Recent Development
Table 139. KuDOS Pharmaceuticals Corporation Information
Table 140. KuDOS Pharmaceuticals Description and Business Overview
Table 141. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. KuDOS Pharmaceuticals Product
Table 143. KuDOS Pharmaceuticals Recent Development
Table 144. National Health Service Corporation Information
Table 145. National Health Service Description and Business Overview
Table 146. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. National Health Service Product
Table 148. National Health Service Recent Development
Table 149. National Institutes of Health Corporation Information
Table 150. National Institutes of Health Description and Business Overview
Table 151. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. National Institutes of Health Product
Table 153. National Institutes of Health Recent Development
Table 154. Tesaro Corporation Information
Table 155. Tesaro Description and Business Overview
Table 156. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Tesaro Product
Table 158. Tesaro Recent Development
Table 159. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 160. Key Challenges
Table 161. Market Risks
Table 162. Main Points Interviewed from Key DNA Repair Drugs Players
Table 163. DNA Repair Drugs Customers List
Table 164. DNA Repair Drugs Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of FiguresFigure 1. DNA Repair Drugs Product Picture
Figure 2. Global DNA Repair Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. PARP Inhibitors Product Picture
Figure 4. Other Product Picture
Figure 5. Global DNA Repair Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Oncological
Figure 7. Stroke
Figure 8. DNA Repair Drugs Report Years Considered
Figure 9. Global DNA Repair Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global DNA Repair Drugs Sales 2015-2026 (K Units)
Figure 11. Global DNA Repair Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global DNA Repair Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global DNA Repair Drugs Sales Market Share by Region in 2019
Figure 14. Global DNA Repair Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global DNA Repair Drugs Revenue Market Share by Region in 2019
Figure 16. Global DNA Repair Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by DNA Repair Drugs Revenue in 2019
Figure 18. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global DNA Repair Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global DNA Repair Drugs Sales Market Share by Type in 2019
Figure 21. Global DNA Repair Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global DNA Repair Drugs Revenue Market Share by Type in 2019
Figure 23. Global DNA Repair Drugs Market Share by Price Range (2015-2020)
Figure 24. Global DNA Repair Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global DNA Repair Drugs Sales Market Share by Application in 2019
Figure 26. Global DNA Repair Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global DNA Repair Drugs Revenue Market Share by Application in 2019
Figure 28. United States DNA Repair Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 29. United States DNA Repair Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. United States DNA Repair Drugs Market Share in Global Market 2015-2026
Figure 31. United States 5 and 10 Largest DNA Repair Drugs Players Market Share by Revenue in DNA Repair Drugs in 2019
Figure 32. United States DNA Repair Drugs Revenue Share by Type (2015-2020)
Figure 33. United States DNA Repair Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 34. United States DNA Repair Drugs Revenue Share by Application (2015-2020)
Figure 35. United States DNA Repair Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America DNA Repair Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America DNA Repair Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America DNA Repair Drugs Sales Market Share by Country in 2019
Figure 39. North America DNA Repair Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe DNA Repair Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe DNA Repair Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe DNA Repair Drugs Sales Market Share by Country in 2019
Figure 47. Europe DNA Repair Drugs Revenue Market Share by Country in 2019
Figure 48. Germany DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. France DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Asia Pacific DNA Repair Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific DNA Repair Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific DNA Repair Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific DNA Repair Drugs Revenue Market Share by Region in 2019
Figure 62. China DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. China DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. India DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand DNA